![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214184
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212744
https://www.upsher-smith.com/news/upsher-smith-launches-propafenone-hydrochloride-extended-release-capsules/
https://www.prnewswire.com/news-releases/upsher-smith-launches-propafenone-hydrochloride-extended-release-capsules-301086220.html
https://www.biospectrumasia.com/news/33/12988/vitruvias-sinotherapeutics-launch-approved-version-of-propafenone-er-in-the-u-s-.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210339
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205956
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-13-2017-1505277974.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205268
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-gets-usfda-approval-for-rythmol-sr-generic/articleshow/60459858.cms
http://www.prnewswire.com/news-releases/mylan-launches-generic-rythmol-sustained-release-capsules-300278388.html
https://www.pharmacompass.com/pdf/news/orion-corp-orions-generic-propafenone-hcl-approved-in-us-as-antiarrhythmic-drug-1463220310.pdf
https://www.pharmacompass.com/pdf/news/mylan-pharms-incs-generic-propafenone-hydrochloride-approved-in-us-1462507896.pdf